Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2751-2760 Newer>

Bio-IT World March 2006 John Russell	It's All About the Drugs A conversation with biopharma Organon's executive VP for global research and development highlights how, regardless of the company's enthusiasm for new technology, it is first and foremost interested in pharmacology and medicinal chemistry -- drugs.
The Motley Fool March 13, 2006 Stephen D. Simpson	Watson Pays Up to Stay in the Game Watson gets bigger, but how much better? The company is buying Andrx for $25 a share. Investors, take note.
Fast Company March 2006 Ramez Naam	The Body: Bulletproof Gene therapy is on its way - and it's coming fast.
BusinessWeek March 20, 2006	Legal Tangle At The Fountain Of Youth There has been new light shed on allegations that Pharmacia Corp. improperly promoted its drug Genotropin to doctors who intended to use it as an anti-aging treatment. The U.S. Justice Dept. is continuing its investigation.
BusinessWeek March 20, 2006	Biotech's Diet In A Bottle Could Extend Your Life A handful of biotech companies are developing drugs that produce the effects of caloric restriction in the body without depriving people of food.
Pharmaceutical Executive March 1, 2006 Ron Feemster	Holding Their Breath: Inhaled Insulin Exubera, Pfizer's inhaled-insulin therapy, is carving out a new market for diabetes drugs. Four more companies are looking for their share.
Pharmaceutical Executive March 1, 2006 Cacciotti & Shew	Pharma's Next Top Model: Slimmer Business Models After almost two decades of blockbuster-driven prosperity, the model for success in pharmaceuticals has broken down. The path forward, once clear, is no longer obvious.
Pharmaceutical Executive March 1, 2006 Sharyn Lee	Invisible Prescribers: What You Do and Don't Know About NPs and PAs How many prescriptions are written each year by nurse practitioners and physician assistants? Pharmaceutical companies not only fail to market to this sector, they neglect to invite nurse practitioners and physician assistants to meetings or to include them in plans for continuing medical education.
Pharmaceutical Executive March 1, 2006 Alana Klein	Direct to Consumer: Q&A with Jill Balderson More Education, Less Promotion. Patient materials should teach rather than tell.
Pharmaceutical Executive March 1, 2006 Dorfman & Maynor	Marketing to Professionals: Under the Influence Pharmaceutical marketers should target the doctors who affect change in the medical community.
<Older 2751-2760 Newer> Return to current articles.